NCT06931860View on ClinicalTrials.gov

Head to Head Trial of Mailed Cologuard to Mailed FIT

NAEnrolling by invitationINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

September 5, 2025

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2027

Conditions
Colorectal Cancer ScreeningFecal Immunochemical TestMulti-target Stool DNAColorectal Cancer (CRC)
Interventions
DIAGNOSTIC_TEST

Cologuard

Multi-target stool DNA test for colorectal cancer screening implemented by Exact Sciences. Cologuard has 94% sensitivity and 87% specificity to detect colorectal cancer.

DIAGNOSTIC_TEST

Fecal Immunochemical Test

Stool blood test for colorectal cancer screening. FIT has 75% sensitivity and 90% specificity to detect colorectal cancer.

Trial Locations (1)

92093

University of California San Diego, La Jolla

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of California, San Diego

OTHER